Davis Andrew

Track

Insider profile

Performance

Overall performance
3.7
Performance over holding periods
3.7
30 days 90 days 120 days
Average return 7% 8.2% 15.1%
Success rate 72% 68% 82%
Transactions
3 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Davis Andrew's trades of Ironwood Pharmaceuticals, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-12-27 2024-12-27
PrS Proposed sale
21,156
140.99
US$1,152,608 		21,156 140.99 US$1,152,608
2024-11-20 2024-11-18
PlS Planned sale
25,505 -25.8%
77.28
US$4,868,154 		25,505 -25.8% 77.28 US$4,868,154
2024-11-15 2024-11-18
PrS Proposed sale
67,279
475.63
US$2,547,912 		67,279 475.63 US$2,547,912
2024-05-22 2024-05-20
S Sale
22,725 -7.3%
6.45
US$146,576 		22,725 -7.3% 6.45 US$146,576
2024-05-17 2024-05-20
PrS Proposed sale
25,105
6.64
US$166,697 		25,105 6.64 US$166,697
2024-02-14 2024-02-12
PlS Planned sale
9,846 -4.5%
15.24
US$150,053 		9,846 -4.5% 15.24 US$150,053
2024-02-09 2024-02-12
PrS Proposed sale
11,519
14.90
US$171,633 		11,519 14.90 US$171,633
2023-11-22 2023-11-20
PlS Planned sale
3,287 -1.5%
9.69
US$31,851 		3,287 -1.5% 9.69 US$31,851
2023-11-17 2023-11-20
PrS Proposed sale
3,859
9.44
US$36,429 		3,859 9.44 US$36,429
2023-05-24 2023-05-22
S Sale
6,305 -2.8%
10.12
US$63,807 		6,305 -2.8% 10.12 US$63,807
2023-05-19 2023-05-22
PrS Proposed sale
7,165
10.22
US$73,226 		7,165 10.22 US$73,226
2023-03-01 2023-02-28
S Sale
1,822 -1.2%
11.31
US$20,607 		1,822 -1.2% 11.31 US$20,607
2023-03-01 2023-02-27
PlS Planned sale
1,751 -1.1%
11.41
US$19,979 		1,751 -1.1% 11.41 US$19,979
2022-11-23 2022-11-21
PlS Planned sale
3,335 -2.1%
11.56
US$38,553 		3,335 -2.1% 11.56 US$38,553